SCHEMBL20182545

SCHEMBL20182545

Cc1cc(F)c(S)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD44 P16070 1/20 0.41
TRPV4 Q9HBA0 1/20 0.35
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
CYP3A4 P08684 1/20 0.33
LMNA P02545 1/20 0.33
RAPGEF4 Q8WZA2 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
PTGS2 P35354 4/20 0.31
PTGS1 P23219 2/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7062222 0.79 CD44 (0.48) CD44GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL17964049 0.79 TRPV4 (0.41) TRPV4ALDH1A1
SCHEMBL29754733 0.79 TRPV4 (0.41) TRPV4ALDH1A1
SCHEMBL7550920 0.77 CD44 (0.46) CD44GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL9918976 0.77 CD44 (0.46) CD44GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL24022105 0.77 TRPV4 (0.44) TRPV4
SCHEMBL3483821 0.77 CD44 (0.46) CD44GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL20063929 0.77 TRPV4 (0.39) TRPV4ALDH1A1
SCHEMBL25036379 0.73 CD44 (0.38) CD44GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL11043190 0.72 CD44 (0.46) CD44GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018093694-A1 DIAMINO-ALKYLAMINO-LINKED ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS MERCK SHARP & DOHME CORP. (US) 2018-05-24 WO disclosed